8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Caveolin-1 Influences LFA-1 Redistribution upon TCR Stimulation in CD8 T Cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          TCR stimulation by peptide–MHC complexes on APCs requires precise reorganization of molecules into the area of cellular contact to form an immunological synapse from where T cell signaling is initiated. Caveolin (Cav)1, a widely expressed transmembrane protein, is involved in the regulation of membrane composition, cellular polarity and trafficking, and the organization of signal transduction pathways. The presence of Cav1 protein in T cells was identified only recently, and its function in this context is not well understood. We show that Cav1-knockout CD8 T cells have a reduction in membrane cholesterol and sphingomyelin, and upon TCR triggering they exhibit altered morphology and polarity, with reduced effector function compared with Cav1 wild-type CD8 T cells. In particular, redistribution of the β 2 integrin LFA-1 to the immunological synapse is compromised in Cav1-knockout T cells, as is the ability of LFA-1 to form high-avidity interactions with ICAM-1. Our results identify a role for Cav1 in membrane organization and β 2 integrin function in primary CD8 T cells.

          Related collections

          Most cited references74

          • Record: found
          • Abstract: found
          • Article: not found

          Caveolin, a protein component of caveolae membrane coats.

          Caveolae have been implicated in the transcytosis of macromolecules across endothelial cells and in the receptor-mediated uptake of 5-methyltetrahydrofolate. Structural studies indicate that caveolae are decorated on their cytoplasmic surface by a unique array of filaments or strands that form striated coatings. To understand how these nonclathrin-coated pits function, we performed structural analysis of the striated coat and searched for the molecular component(s) of the coat material. The coat cannot be removed by washing with high salt; however, exposure of membranes to cholesterol-binding drugs caused invaginated caveolae to flatten and the striated coat to disassemble. Antibodies directed against a 22 kd substrate for v-src tyrosine kinase in virus-transformed chick embryo fibroblasts decorated the filaments, suggesting that this molecule is a component of the coat. We have named the molecule caveolin. Caveolae represent a third type of coated membrane specialization that is involved in molecular transport.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Ligand binding to integrins.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.

              Caveolin-1 is the principal structural protein of caveolae membranes in fibroblasts and endothelia. Recently, we have shown that the human CAV-1 gene is localized to a suspected tumor suppressor locus, and mutations in Cav-1 have been implicated in human cancer. Here, we created a caveolin-1 null (CAV-1 -/-) mouse model, using standard homologous recombination techniques, to assess the role of caveolin-1 in caveolae biogenesis, endocytosis, cell proliferation, and endothelial nitric-oxide synthase (eNOS) signaling. Surprisingly, Cav-1 null mice are viable. We show that these mice lack caveolin-1 protein expression and plasmalemmal caveolae. In addition, analysis of cultured fibroblasts from Cav-1 null embryos reveals the following: (i) a loss of caveolin-2 protein expression; (ii) defects in the endocytosis of a known caveolar ligand, i.e. fluorescein isothiocyanate-albumin; and (iii) a hyperproliferative phenotype. Importantly, these phenotypic changes are reversed by recombinant expression of the caveolin-1 cDNA. Furthermore, examination of the lung parenchyma (an endothelial-rich tissue) shows hypercellularity with thickened alveolar septa and an increase in the number of vascular endothelial growth factor receptor (Flk-1)-positive endothelial cells. As predicted, endothelial cells from Cav-1 null mice lack caveolae membranes. Finally, we examined eNOS signaling by measuring the physiological response of aortic rings to various stimuli. Our results indicate that eNOS activity is up-regulated in Cav-1 null animals, and this activity can be blunted by using a specific NOS inhibitor, nitro-l-arginine methyl ester. These findings are in accordance with previous in vitro studies showing that caveolin-1 is an endogenous inhibitor of eNOS. Thus, caveolin-1 expression is required to stabilize the caveolin-2 protein product, to mediate the caveolar endocytosis of specific ligands, to negatively regulate the proliferation of certain cell types, and to provide tonic inhibition of eNOS activity in endothelial cells.
                Bookmark

                Author and article information

                Journal
                J Immunol
                J. Immunol
                jimmunol
                jimmunol
                JI
                The Journal of Immunology Author Choice
                AAI
                0022-1767
                1550-6606
                1 August 2017
                21 June 2017
                : 199
                : 3
                : 874-884
                Affiliations
                [* ]Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh EH9 3FL, United Kingdom;
                []University of Glasgow, Glasgow G12 8TA, United Kingdom;
                []Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE1 7RU, United Kingdom; and
                [§ ]Institute of Biotechnology, University of Helsinki, 00014 Helsinki, Finland
                Author notes
                Address correspondence and reprint requests to Prof. Rose Zamoyska, Institute of Immunology and Infection Research, University of Edinburgh, Charlotte Auerbach Road, Edinburgh EH9 3FL, U.K. E-mail address: Rose.Zamoyska@ 123456ed.ac.uk
                Author information
                http://orcid.org/0000-0003-0704-1254
                http://orcid.org/0000-0003-4743-9013
                http://orcid.org/0000-0001-9816-2638
                Article
                ji_1700431
                10.4049/jimmunol.1700431
                5523581
                28637901
                cbb11a3a-b4cb-47bf-a0db-4f9ec745dee2
                Copyright © 2017 The Authors

                This article is distributed under the terms of the CC BY 4.0 Unported license .

                History
                : 23 March 2017
                : 19 May 2017
                Page count
                Figures: 6, Equations: 0, References: 84, Pages: 11
                Categories
                Antigen Recognition and Responses

                Comments

                Comment on this article